Skip to main content

IPO-bound PharmEasy buys Thyrocare; is it worth the price and what does this means for diagnostic sector?

IPO-bound PharmEasy buys Thyrocare; is it worth the price and what does this means for diagnostic sector? Several analysts and competitors Moneycontrol spoke to said that the deal would be a win-win for PharmEasy and shareholders of Thyrocare and more importantly for Velumani, the Chairman of Thyrocare, who will be cashing out.

from Moneycontrol Business News https://www.moneycontrol.com/news/business/ipo-bound pharmeasy-buys-thyrocare-is-it-worthpricewhat-does-this-means-for-diagnostic-sector_15232781.html
Labels:

Comments

Post a Comment

Popular posts from this blog

German cabinet to hold secret session on Huawei#39;s role in 5G network: Report

Huawei faces international scrutiny over its ties with the Chinese government and suspicion that Beijing could use Huawei#39;s technology for spying, which the company denies. from Moneycontrol Business News http://bit.ly/2TyXzFb
Post a Comment
Read more

List of tax defaulters to be published from Friday: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yToJRc
Post a Comment
Read more

List of tax defaulters to be published from tomorrow: Kiran Bedi

Bedi had said the government would publish the names of defaulters in newspapers and also announce them on FM radio channels. from Moneycontrol Business News https://ift.tt/2yU0Uch
Post a Comment
Read more